Abstract:Drug-coated balloon (DCB) angioplasty is one of the potential approaches to alleviating in-stent restenosis and treating peripheral artery disease. An in-silico model has been developed for sirolimus drug eluted from an inflated balloon in a patient-specific arterial cross-section consisting of fibrous tissue, fibrofatty tissue, dense calcium, necrotic core, and healthy tissue. The convection-diffusion-reaction equation represents the transport of drug, while drug binding, both specific and non-specific, can be modelled as a reaction process. The Brinkman equations describe the interstitial flow in porous tissue. An image processing technique is leveraged for reconstructing the computational domain. The Marker and Cell, and Immersed Boundary Methods are used to solve the set of governing equations. The no-flux interface condition and convection do amplify the tissue content, and the regions of dense calcium and necrotic core limited to or extremely close to the interface pose a clinical threat to DCB therapy. Simulations predict the effects of the positioning and clustering of plaque components in the domain. This study demands extensive intravascular ultrasound-derived virtual histology (VH-IVUS) imaging to understand the plaque morphology and determine the relative positions of different plaque compositions about the lumen-tissue interface, which have a significant impact on arterial pharmacokinetics.

What problem does this paper attempt to address?

The paper attempts to address the following issues: 1. **Key Issues in Drug-Coated Balloon (DCB) Therapy**: - The paper explores the challenges faced by drug-coated balloons (DCB) in treating in-stent restenosis (ISR) and peripheral artery disease. Despite DCB being a promising technology, there is significant drug loss (about 80-90%) and difficulty in drug penetration in severely calcified lesions. 2. **Impact of Plaque Heterogeneity on Drug Delivery**: - The study focuses on how the spatial distribution and heterogeneity of plaque components affect drug delivery efficacy. Specifically, the impact of different combinations of fibrous tissue, fibro-fatty tissue, dense calcification, necrotic core, and healthy tissue on drug delivery and retention. 3. **Modeling Drug Binding Mechanisms**: - The paper proposes a model based on nonlinear reversible chemical reaction processes to simulate the specific and non-specific binding of drugs to specific receptors and the extracellular matrix. The transport of free drugs is described using convection-diffusion-reaction equations, and the specific and non-specific binding is simulated through reaction processes. 4. **Application of Image Processing Techniques**: - Image processing techniques are used to reconstruct the computational domain, with automatic detection and segmentation of different plaque components based on virtual histology intravascular ultrasound (VH-IVUS) imaging. 5. **Comparative Analysis of Different Models**: - Three different models are considered: a healthy model (only healthy tissue), a hard model (healthy tissue + dense calcification + necrotic core), and a soft model (healthy tissue + fibrous tissue + fibro-fatty tissue). These models are used to evaluate the impact of different plaque components on drug distribution and retention. 6. **Choice of Numerical Simulation Methods**: - The Marker and Cell (MAC) and Immersed Boundary Method (IBM) are used to solve the governing equations to obtain a quantitative understanding. Through the above research, the paper aims to better understand the key factors affecting the efficacy of DCB therapy and provide a theoretical basis for optimizing DCB therapy.

Plaque heterogeneity and the spatial distributions of its components dictate drug-coated balloon therapy

The factors influencing the efficiency of drug-coated balloons

Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy

Drug-coated balloons for coronary artery disease: An updated review with future perspectives

Computational replication of the patient-specific stenting procedure for coronary artery bifurcations: From OCT and CT imaging to structural and hemodynamics analyses

Drug-Coated Balloons in the Management of Coronary Artery Disease

Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group

Neointimal characteristic changes following drug-coated balloons in lesions with repeated revascularization

Plaque‐Specific Adhesive Balloons Coated with Calcium Phosphate Nanoparticles Loaded with Rapamycin for Atherosclerosis Therapy

Performance of drug-coated balloons in coronary and below-the-knee arteries: Anatomical, physiological and pathological considerations

Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in patients with coronary In-Stent Restenosis: A systematic review and meta-analysis of randomized controlled trials

Provisional Drug-Coated Balloon Treatment Guided by Physiology on De Novo Coronary Lesion

Numerical Simulation of Local Pharmacokinetics of a Drug after Intravascular Delivery with an Eluting Stent

Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

What are the Pathological Concerns and Limitations of Current Drug-coated Balloon Technology?

Benefits and Challenges of Drug-Coated Balloons in Peripheral Artery Disease: From Molecular Mechanisms to Clinical Practice

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

Computational modeling of in-stent restenosis: Pharmacokinetic and pharmacodynamic evaluation

Meta-Analysis Comparing Drug-Coated Balloon Versus Plain Old Balloon Angioplasty for In-stent Restenosis of Coronaries

In silico study of patient-specific magnetic drug targeting for a coronary LAD atherosclerotic plaque